MSCLF (Satellos Bioscience) Preferred Dividends : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Satellos Bioscience's preferred dividends for the three months ended in Sep. 2024 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Satellos Bioscience Preferred Dividends Historical Data

The historical data trend for Satellos Bioscience's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Preferred Dividends Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Preferred Dividends	Get a 7-Day Free Trial												-	-	-	-	-

Satellos Bioscience Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Satellos Bioscience (OTCPK:MSCLF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Satellos Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (OTCPK:MSCLF) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

0IT:Germany MSCL:Canada

Address

200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.